DiaMedica Therapeutics Inc
Statements
Cash Flow
DiaMedica Therapeutics Inc (DMAC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -29 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.8 | -1.4 | -3.0 | -3.9 | -5.7 | -9.1 | -9.2 | -12 | -12 | -19 | -22 | -29 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 | |
| 0.3 | 0.1 | 0.3 | 0.4 | 0.6 | 1.2 | 1.8 | 1.6 | 1.5 | 1.7 | 2.1 | 3.8 | |
| 0.6 | 0.3 | 0.1 | 0.4 | 0.7 | 1.2 | 1.8 | 1.8 | 1.6 | – | – | – | |
| 0.4 | -0.1 | -0.9 | 0.0 | -0.6 | 0.4 | 1.2 | -0.5 | 0.6 | 0.1 | 1.5 | 0.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -3.9 | -16 | -21 | 12 | -18 | 8.6 | -2.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 1.4 | 1.5 | 4.6 | 3.5 | 21 | 0.1 | 29 | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.7 | 1.4 | 4.6 | 3.5 | 21 | 0.1 | 29 | 30 | 0.0 | 37 | 12 | 44 | |
| -2.1 | 0.0 | 1.6 | -0.4 | 15 | -13 | 3.5 | -2.7 | 0.0 | -0.2 | -1.5 | 13 | |
| -3.8 | -1.4 | -3.0 | -3.9 | -5.7 | -9.1 | -9.2 | -12 | -12 | -19 | -22 | -29 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.